Dr. Shaha specializes in head and neck surgery, with a particular interest in thyroid and parathyroid surgery. He uses an algorithm of selective thyroid tumor criteria (the size, location, stage and type of cancer, along with the patient’s age), to tailor therapy to each individual’s circumstances. This can help thyroid cancer patients avoid unnecessary and potentially damaging over-treatment, while still providing the best option for control of their cancer and better quality of life after treatment. Dr. Shaha works very closely with Memorial Sloan Ketterings’ endocrinologists to monitor the careful post-treatment hormone balancing necessary for thyroid cancer patients. Many academic hospitals and medical societies worldwide have invited Dr. Shaha to speak on the principles of targeted thyroid surgery and to share his expertise in the treatment of head and neck cancers.
His well-established authority in head and neck oncologic surgery has resulted in honors from the American Academy of Otolaryngology—Head and Neck Surgery and the Society of Head and Neck Surgeons. He has been elected to top leadership positions in the American Head and Neck Society, the American Association of Endocrine Surgeons, the New York Head and Neck Society, the New York Cancer Society, the New York Surgical Society, the Brooklyn Surgical Society, and the American Society for Surgeons of Indian Origin.
Dr. Shaha serves on the boards of the Journal of Surgical Oncology, Head and Neck, the Annals of Surgical Oncology, the Brazilian Journal of Surgery, and the Gulf Journal of Medicine. He has published more than 275 peer-reviewed scientific articles and more than 125 invited articles.
Noted for his commitment and skill in educating physicians, he has chaired several international conferences, and currently serves as the Chairman of the American Head and Neck Society’s Advanced Training Council, the society granting academic approval to head and neck surgical programs and trainees. He relishes his involvement in training the next generation of head and neck surgeons, and is the recipient of outstanding teaching awards from Memorial Sloan Kettering and SUNY Downstate Medical Center in Brooklyn.
- Clinical Expertise: Head and Neck Surgery/Oncology; Thyroid Surgery
- Languages Spoken: English
- Education: MD, Medical College, University of Baroda (India)
- Residencies: Maharaja Sayajirao University (Baroda, India); Tata Memorial Hospital (Bombay, India)
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Surgery
Proceedings of the Fifth International Head and Neck Oncology Meeting. Johnson J, Shaha AR. Los Angeles: American Head and Neck Society; 2000.
Operative Techniques in Otolaryngology – Head and Neck Surgery. Shaha AR. Philadelphia: WB Saunders; 2003.
Operative Techniques in General Surgery. Shaha AR, van Heerden J, Farley DR, eds. Philadelphia: WB Saunders; 2004.
Proceedings of the Sixth International Head and Neck Meeting. Shaha AR, Weymueller E. Washington, DC: American Head and Neck Society; 2004.
Selected Book Chapters
“Differentiated thyroid carcinoma.” Shaha AR, Lim D. In: Prognosis and outcomes in surgical disease. McKellar DP, Reiling RB, Eiseman B, eds. St Louis: Quality Medical Publishing; 1999: 18-19.
“Medullary thyroid cancer.” Shaha AR, Lim D. In: Prognosis and Outcomes in Surgical Disease. McKellar DP, Reiling RB, Eiseman B, eds. St Louis: Quality Medical Publishing; 1999:20-21.
“Anaplastic thyroid cancer.” Shaha AR. In: Endocrine Surgery. Prinz RA and Staren E, eds. Georgetown, TX: Landes Bioscience; 2000: 80-86.
“Prognostic factors and risk groups in well-differentiated thyroid cancer.” Shaha AR. In: Endocrine Surgery of the Head and Neck. Pelliteri PK, McCaffrey TV, eds. Clifton Park, NY: Thomson Delmar Learning; 2002.
“Follicular carcinoma of the thyroid.” Shaha AR, Shah JP. In: Surgery of the Thyroid and Parathyroid. Randolph G, ed. Philadelphia; WB Saunders; 2003.
“How to preserve the parathyroid glands during thyroid surgery.” Shaha AR, de Araujo Filho VF. In: Pearls and Pitfalls in Head and Neck Surgery. Cerneo CR, ed. New York, NY: Karger; 2008: 8-9.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more